A study involving thousands of COVID-19 patients in Britain suggests that a low-cost steroid drug known as dexamethasone could significantly reduce the death rate for those sick enough to require respiratory support.
A study involving thousands of COVID-19 patients in Britain suggests that a low-cost steroid drug known as dexamethasone could significantly reduce the death rate for those sick enough to require respiratory support.